Home › Funds › Tetragon Partners GP Ltd › IONS

Tetragon Partners GP Ltd position in IONS

IONIS PHARMACEUTICALS INC · Health Care

Tetragon Partners GP Ltd reported holding 440,930 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 2.69% of its reported portfolio and ranking #4 among its reported holdings. Tetragon Partners GP Ltd has disclosed IONS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)440.93K sh
Reported value held$19.69M
Portfolio Weight2.69%
First reportedQ1 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Tetragon Partners GP Ltd's IONS position evolved

Tetragon Partners GP Ltd first disclosed a stake in IONS in Q1 2026 at 41,764 shares (US$3.1M). The position peaked in Q3 2026 at 440,930 shares, worth US$19.7M. Across 3 filings, Tetragon Partners GP Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 440,930 shares valued at US$19.7M — an increase of 343,757 shares quarter over quarter.. Notable position changes include a 133% increase in Q2 2026 (shares fell 44% over the following quarter), a 354% increase in Q3 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 41.76K $3.14M New
Q2 2026 97.17K $7.70M Add
Q3 2026 440.93K $19.69M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$300.4M), TWO SIGMA ADVISERS, LP (US$241.5M), BAKER BROS. ADVISORS LP (US$162.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has Tetragon Partners GP Ltd held IONS?

Tetragon Partners GP Ltd has disclosed IONS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Tetragon Partners GP Ltd's current position in IONS?

As of Q3 2026, Tetragon Partners GP Ltd holds 440.93K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $19.69M, representing 2.69% of its reported portfolio and ranking #4.

Has Tetragon Partners GP Ltd been buying or selling IONS?

In the latest 13F filing (Q3 2026), Tetragon Partners GP Ltd increased its position in IONS. The position peaked in Q3 2026 at 440.93K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, BAKER BROS. ADVISORS LP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.